Clinical Trial Update: Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes

View source ↗

Summary

A Takeda-sponsored cohort study evaluating pioglitazone in patients with type 2 diabetes for bladder cancer risk; the trial is completed and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Takeda | Conditions: Diabetes, Bladder Cancer | Status: COMPLETED | Results posted: 2012-10-12